Carlos Alberto
Montilla Morales
Profesor Asociado CC. Salud
Hospital Clinic Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Hospital Clinic Barcelona (21)
2023
-
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 137-144
-
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model
Seminars in Arthritis and Rheumatism, Vol. 57
-
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
Arthritis research & therapy, Vol. 24, Núm. 1, pp. 153
-
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
Frontiers in Medicine, Vol. 9
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2018
-
Recommendations for the use of methotrexate in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 4, pp. 183-190
-
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 5, pp. 254-268
2016
-
Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis
Clinical Rheumatology, Vol. 35, Núm. 7, pp. 1789-1794
-
Etoricoxib in ankylosing spondylitis: Is there a role for active patients refractory to traditional NSAIDs?
Clinical and Experimental Rheumatology, Vol. 34, Núm. 1, pp. 94-99
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
2014
-
Ankylosing spondylitis without axial progression: Analysis of associated factors
Journal of Rheumatology, Vol. 41, Núm. 12, pp. 2409-2412
-
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769
-
Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: A Delphi study
Actas Dermo-Sifiliograficas
2013
-
Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER
Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225
2012
-
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: A longitudinal study with 6 months of followup
Journal of Rheumatology, Vol. 39, Núm. 5, pp. 1035-1041